Abstract
L-tryptophan was linked with an outbreak of eosinophilic myalgia syndrome (EMS) accounting for at least 1580 clinical cases and 38 deaths [1]. This editorial examines the misguided linkage of L-tryptophan with EMS, presents the facts as they have emerged and recommends steps to avoid future health risks linked to contaminants introduced during manufacture of foods or dietary supplements.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
